IV Tubing Sets and Accessories Market Segmented By Product - Primary IV Tubing Sets | Secondary IV Tubing Sets | Extension IV Tubing Sets | IV Infusion Set with Flow Regulator | Filtered IV Tubing Sets | Non-vented IV Tubing Sets | Vented IV Tubing Sets | IV Tubing Accessories
Industry: Healthcare
Published Date: December-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 245
Report ID: PMRREP20608
The global revenue from the IV tubing sets and accessories market stands at US$ 1.1 Bn in 2022, with the global market expected to grow at a CAGR of 3.5% to reach a valuation of approximately US$ 1.6 Bn by the end of 2033.
|
Market Size (2022) |
US$ 1.1 Bn |
|
Projected Market Value (2033) |
US$ 1.6 Bn |
|
Global Market Growth Rate (2023-2033) |
3.5% CAGR |
|
Market Share of Top 4 Countries |
43.3% |
As assessed by Persistence Market Research, primary IV tubing sets hold a market share of around 29.1% in 2022. Overall, IV tubing sets and accessories market sales account for approximately 8.2% revenue share in the global IV equipment market, which was valued at around US$ 13.63 Bn in 2022.
The global market recorded a historic CAGR of 3.6% in the last 10 years from 2012 to 2022.
Over the past few years, consumption for IV tubing sets and related accessories has significantly increased due to the growing prevalence of feeding issues in children with esophageal atresia (EA). The main reasons for the switch to tube feeding are difficulty swallowing, choking, oral aversion, food rejection, coughing, and others.
As a result, the market is now generating more revenue. Dysphagia induces reduced meal intake, which lowers basal metabolic rate and lowers calorie demands.
Additionally, one of the common conditions that contributes to the rise in dysphagia is stroke. Out of all stroke victims, 50.0% of patients have dysphagia and need speech therapy because they have trouble eating. However, 20.0% of people regain their capacity on their own, with significant long-term feeding issues accounting for 30% of cases.
Additionally, between 50 and 75 percent of patients in homecare institutions have dysphagia. The need for IV tubing sets to administer fluids and medications into the body is growing at a gradual pace due to reduced appetite and an increase in swallowing difficulties. As a result, the market is experiencing increased revenue.
The global market is thus likely to show high growth over the coming years at a CAGR of 3.5% and reach a global market size of US$ 1.6 Bn by 2033.
“Rising R&D Investments in Asia Pacific, and Increasing Number of Manufacturers Providing High Quality IV Tubing”
Major sectors have seen a shift in recent years from North America and Europe to Asia Pacific in terms of investment in R&D and technology, particularly in the life sciences and biotechnology industries. The opportunity for outsourcing biotech projects is boosted by the presence of skilled work force and qualified personnel in emerging economies like India at affordable pricing. India contributed for nearly 40% of all investments made in the international engineering and R&D sector in 2016.
Additionally, a number of governments in these areas have begun to take action to support the expansion of the local biotechnology and healthcare industries by providing tax exemptions for R&D, increasing budgets and funding, forming public and private conglomerates, and luring foreign direct investments, among other measures.
To advance the biomedical sciences cluster of pharmaceuticals, medical technology, biotechnology, and healthcare services in Singapore, the Economic Development Board, Bio*One Capital, as well as Biomedical Research Council (BMRC) established the Biomedical Sciences (BMS) group. This partnership aims to increase investment and research in medical equipment and related technology.
Despite the industry having a number of major participants as well as numerous smaller businesses on a regional and international scale, there are many businesses that are only focused on being manufacturers of IV tube sets for the purpose of infusion therapy.
While different manufacturers have varied specialties and product lines, the majority of significant businesses combine several IV tubing sets to provide an advanced IV tubes with enhanced structural characteristics.
Over the coming years, it is anticipated that R&D spending on medical equipment will increase steadily, as will investment in the production of IV tube sets and associated components. Companies that invest in providing various administration products to cater these markets will anticipate stable returns.
“Regulatory Impositions and Cost Constraints”
Stringent regulatory requirements for the introduction of novel products is a major factor hindering the growth of the overall market. The FDA has strict regulatory requirements. Investments in the sector are being shifted overseas as a result of regulatory challenges, which is a constraint on the global market.
Without more predictability and openness from the FDA, new product introduction is challenging for both small and large device makers. A new medical equipment is introduced to the U.S. market one to three years later than it is in the E.U. from a chronology viewpoint.
In addition, concerns such as the negative effects connected with infusion accessories and the elevated costs are anticipated to limit market expansion. Highly priced and expensive medical equipment is imported with hard-earned foreign currency, used for a while, and then discarded for lack of maintenance.
Moreover, with the rising considerations in sustainable manufacturing, as well as the disposal of medical equipment, the demand within the market experiences a decline.
These factors are thus set to restrain the growth of the overall market over the projected time frame.
Why is the U.S. IV Tubing Sets and Accessories Market Booming?
“Growing Burden of Disease and Growing Healthcare Sector”
The U.S. accounted for around 24.7% market share in the global market in 2022.
Due to an ageing population, a rise in diseases with significant burden, and an increase in the adoption of cutting-edge healthcare technologies, the U.S. retains a sizable market share in the global market. The rising prevalence of chronic diseases brought on by the ageing population and the expanding adoption of IV therapy in its management are both contributing to the expansion of the market in this segment.
Additionally, rising healthcare costs and the existence of a solid healthcare infrastructure are both major drivers of the expansion of the market within the country.
Will Germany Be a Lucrative Market for IV Tubing Sets and Accessories?
“Presence of Reimbursement Policies”
Germany held around 9.3% market share of the global market in 2022. A key driver of the rising demand within the market is the availability of highly qualified and competent specialists and technicians to administer IV administration devices.
The majority of regional producers give reimbursement for different IV administration regimens. Since there are specific guidelines that must be followed while using IV tubing sets, the availability of qualified technicians is attracting larger numbers of patients for surgeries, which is fostering future growth for the overall market within Germany.
Additionally, market growth is fuelled by the region's constantly changing reimbursement environment for IV tubing sets and the rising prevalence of chronic diseases.
How is Japan Emerging as a Prominent Market?
“Rising Demand for Minimally Invasive Procedures and Availability of Technologically Enhanced Products”
Japan held a market share of about 4.0% of the global IV tubing sets and accessories market in 2022. The usage of IV tubing sets and accessories has expanded as a result of the rising demand for minimally invasive procedures and the availability of technologically superior IV administration sets.
Modern IV sets are in high demand because they provide patients with a higher level of accuracy and precision in drug delivery, which reduces dose and medication administration errors. The market for technologically sophisticated IV tubing sets and accessories is anticipated to be driven by IV tubing accessories such as needleless connectors, which due to their design reduce the risk of disease transmission and patient injury.
Additionally, having access to IV tubing sets with add-on attachments like filters and flow regulators has resulted in efficient drug administration practices.
Which Product is Driving Demand within the Global Market?
“First Line of Equipment Adopted for Treatment”
The primary IV tubing sets segment held around 29.1% of the total market in 2022. A thin, bendable plastic tube known as the infusion set is referred to as the primary administration set. The intravenous (IV) fluid bag or bottle is attached to this administration set. For the intermittent or continuous administration of fluids or medications, primary IV tube sets are employed.
It consists of the Backcheck valve, which stops fluid or medication from moving up the IV, and the Access ports, which are utilised for IV push medication administration and secondary medication infusion.
The primary administration set is specifically utilised for continuous fluid or drug infusion. It is the one that is directly placed into the IV fluid container or bag.
Which Application for IV Tubing Sets and Accessories is Largely of Focus within the Global Market?
“Ease of Medication Administration during Peripheral Intravenous Catheter Insertion”
Peripheral intravenous catheter insertion held a share of about 45.6% in 2022 globally.
When administering drugs, fluids, or blood products, a cannula or catheter known as a peripheral IV device is placed into a small peripheral vein. A central line is also preferred by doctors over a typical IV line because: It can be left in place for a longer period of time.
It makes blood collection simpler. Large doses of fluids or medications may be administered to individuals who cannot receive them through regular IVs, thus propelling the applicability of the segment within the global market.
Which End User Provides the Global IV Tubing Sets and Accessories Market With a Large Share?
“Growing Number of Hospitalized Patients Owed to Rise in Chronic Disease Burden”
The hospitals segment held a share of about 41.1% in 2022 globally. One of the main causes of the high prevalence of chronic diseases is the rapid increase in the population of older individuals along with the high prevalence of risk factors, such as increasing tobacco consumption and physical inactivity.
Moreover, as the prevalence of chronic diseases rises, so do the odds that a person may end up in the hospital or dying prematurely. As a result, the prevalence of chronic disorders is increasing the need for IV administration sets and accessories in the management of chronic diseases through infusion of therapeutic fluids into the patient's body via peripheral or central intravenous infusion, consequently fueling market expansion.
Which Age Group Drives the Global Market Sales?
“Rising Disposable Incomes, and Growing Global Volumes of Surgical Procedures”
The adult age group segment held a share of about 76.7% in 2022 in the global market. Rising issues related to lifestyle disorders, growing disposable incomes, as well as the adoption of home healthcare services, are factors propelling the uptake of the IV tubing equipment and accessories among the adult age group.
Additionally, rising volumes of surgical procedures, as well as the availability of reimbursement programs for treatment are factors further propelling the segment value within the global market.
IV tubing set producers prioritise employing high-quality components to develop products that are reliable and simple to use in range of health care settings.
Partnerships with distributors as well as other channel partners ensure continuous product availability and increase the product's geographic reach as well as its applicability in non-traditional end use environments. Manufacturers use a variety of key strategies to enhance product sales across different geographies, including mergers, acquisitions, infrastructure investments, new product introductions, and the introduction of new technologies.
In addition, manufacturers are placing greater emphasis on forward integration through alliances with distributors, wholesalers, as well as other channel partners to take control of the value chain.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the IV tubing sets and accessories market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2012-2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
End User:
Age Group:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 1.1 Bn in 2022.
Sales of the market are set to witness growth at a CAGR of 3.5% and be valued at around US$ 1.6 Bn by 2033.
Demand for the global market increased at a 3.6% CAGR from 2012 to 2022.
The U.S., Germany, Japan, and Australia account for most demand within the market, currently holding around 43.3% market share.
The U.S. is set to account for around 24.7% share of the global market in 2023.
Europe is set to expand at a CAGR rate of 3.7% over the forecast period.
Japan held a market share of about 4.0% of the global IV tubing sets and accessories market in 2022
The U.K. market is set to expand at 3.1% CAGR over the forecast period.
The China market is expected to grow at 5.1% CAGR during the forecast period.
The market in India is set to expand at a 5.8% CAGR over the forecast period.
